Crossmark

Fully bioresorbable vascular scaffolds: lessons learned and future directions

Crossref DOI link: https://doi.org/10.1038/s41569-018-0124-7

Published Online: 2018-12-13

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jinnouchi, Hiroyuki

Torii, Sho

Sakamoto, Atsushi

Kolodgie, Frank D.

Virmani, Renu

Finn, Aloke V.
License Information

Text and Data Mining valid from 2018-12-13
More Information

Article History

First Online: 13 December 2018

Competing interests

: CVPath Institute has received institutional research support from 480 Biomedical, Abbott Vascular, ART, BioSensors International, Biotronik, Boston Scientific, Celonova, Claret Medical, Cook Medical, Cordis, Edwards Lifescience, Medtronic, MicroPort, MicroVention, OrbusNeich, ReCore, SINO Medical Technology, Spectranetics, Surmodics, Terumo Corporation, W.L. Gore and Xeltis. S.T. receives research grants from SUNRISE laboratory. R.V. has received honoraria from 480 Biomedical, Abbott Vascular, Boston Scientific, Cook Medical, Lutonix, Medtronic, Terumo Corporation and W.L. Gore; and is a consultant for 480 Biomedical, Abbott Vascular, Medtronic and W.L. Gore. A.V.F. has received honoraria from Abbott Vascular, Amgen, Boston Scientific, Cook Medical, Lutonix and W.L. Gore. The other authors report no competing interests.